Common design and data elements on rectal artery embolization for treatment of symptomatic internal hemorrhoidal disease: an interactive systematic review of clinical trials.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Samah Morsi, Marisabel Linares Bolsegui, Hassan Kobeissi, Sherief Ghozy, David F Kallmes, Scott R Kelley, Kellie L Mathis, Eric J Dozois, Conor G Loftus, Emily C Bendel, Vincent Vidal, Scott M Thompson
{"title":"Common design and data elements on rectal artery embolization for treatment of symptomatic internal hemorrhoidal disease: an interactive systematic review of clinical trials.","authors":"Samah Morsi, Marisabel Linares Bolsegui, Hassan Kobeissi, Sherief Ghozy, David F Kallmes, Scott R Kelley, Kellie L Mathis, Eric J Dozois, Conor G Loftus, Emily C Bendel, Vincent Vidal, Scott M Thompson","doi":"10.1186/s42155-024-00458-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Internal hemorrhoids (IH) is a common medical condition that can result in morbidity secondary to bleeding and discomfort. Treatment for IH has traditionally consisted of dietary and conservative medical management, focal treatments including banding and sclerotherapy or hemorrhoidectomy. Recently, rectal artery embolization (RAE) has been studied as a potential treatment for bleeding predominant IH. We performed a common design and data element analysis of studies that report on RAE.</p><p><strong>Materials and methods: </strong>We conducted a qualitative systematic literature review for rectal artery embolization (RAE) for symptomatic hemorrhoidal disease. The screening process involved five online databases (PubMed, Embase, Google Scholar, DOAJ, and Scopus). Additionally, ClinicalTrials.gov was examined for active, unpublished completed studies. The initial search yielded 2000 studies, with 15 studies meeting the inclusion criteria after screening and assessment. The included studies comprised one RCT, one case series, one pilot study and 12 cohort studies.</p><p><strong>Results: </strong>The population analysis revealed a male predominance across all studies, with varying cohort sizes. The baseline Goligher hemorrhoid grade was utilized in 80% of studies. The majority (73.3%) employed a transfemoral approach, and coils were the primary embolic material in 60% of studies, 26.6% were combination of coils and particles, and 6.6% were particles only. Patient selection criteria highlighted RAE's applicability for high surgical risk patients and those with anemia, chronic hematochezia, or treatment-refractory cases. Exclusion criteria emphasized factors such as previous surgeries, colorectal cancer, rectal prolapse, acute hemorrhoidal complications, and contrast allergy. Study designs varied, with cohort studies being the most common (12/15; 80%). Procedural details included the use of metallic coils and detachable micro-coils, with a high technical success rate reported in most studies ranging from 72 to 100%. The follow-up ranged from 1 to 18 months. The majority of studies reported no major immediate or post-procedural complications.</p><p><strong>Conclusion: </strong>While all studies focused on RAE as a treatment for IH, there was a great degree of heterogeneity among included studies, particularly regarding inclusion criteria, exclusion criteria, outcomes measures and timeframe. Future literature should attempt to standardize these design elements to help facilitate secondary analyses and increase understanding of RAE as a treatment option.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088570/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CVIR Endovascular","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42155-024-00458-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Internal hemorrhoids (IH) is a common medical condition that can result in morbidity secondary to bleeding and discomfort. Treatment for IH has traditionally consisted of dietary and conservative medical management, focal treatments including banding and sclerotherapy or hemorrhoidectomy. Recently, rectal artery embolization (RAE) has been studied as a potential treatment for bleeding predominant IH. We performed a common design and data element analysis of studies that report on RAE.

Materials and methods: We conducted a qualitative systematic literature review for rectal artery embolization (RAE) for symptomatic hemorrhoidal disease. The screening process involved five online databases (PubMed, Embase, Google Scholar, DOAJ, and Scopus). Additionally, ClinicalTrials.gov was examined for active, unpublished completed studies. The initial search yielded 2000 studies, with 15 studies meeting the inclusion criteria after screening and assessment. The included studies comprised one RCT, one case series, one pilot study and 12 cohort studies.

Results: The population analysis revealed a male predominance across all studies, with varying cohort sizes. The baseline Goligher hemorrhoid grade was utilized in 80% of studies. The majority (73.3%) employed a transfemoral approach, and coils were the primary embolic material in 60% of studies, 26.6% were combination of coils and particles, and 6.6% were particles only. Patient selection criteria highlighted RAE's applicability for high surgical risk patients and those with anemia, chronic hematochezia, or treatment-refractory cases. Exclusion criteria emphasized factors such as previous surgeries, colorectal cancer, rectal prolapse, acute hemorrhoidal complications, and contrast allergy. Study designs varied, with cohort studies being the most common (12/15; 80%). Procedural details included the use of metallic coils and detachable micro-coils, with a high technical success rate reported in most studies ranging from 72 to 100%. The follow-up ranged from 1 to 18 months. The majority of studies reported no major immediate or post-procedural complications.

Conclusion: While all studies focused on RAE as a treatment for IH, there was a great degree of heterogeneity among included studies, particularly regarding inclusion criteria, exclusion criteria, outcomes measures and timeframe. Future literature should attempt to standardize these design elements to help facilitate secondary analyses and increase understanding of RAE as a treatment option.

直肠动脉栓塞治疗症状性内痔疾病的通用设计和数据要素:临床试验互动式系统回顾。
背景:内痔(IH)是一种常见疾病,可因出血和不适而导致发病。传统的内痔治疗方法包括饮食治疗和保守治疗,病灶治疗包括环扎和硬化剂注射或痔切除术。最近,直肠动脉栓塞术(RAE)作为治疗以出血为主的 IH 的一种潜在方法得到了研究。我们对报道 RAE 的研究进行了共同设计和数据元素分析:我们对直肠动脉栓塞术(RAE)治疗症状性痔疮疾病进行了定性系统文献综述。筛选过程涉及五个在线数据库(PubMed、Embase、Google Scholar、DOAJ 和 Scopus)。此外,临床试验网(ClinicalTrials.gov)也对活跃的、未发表的已完成研究进行了检查。初步搜索共获得 2000 项研究,经过筛选和评估,有 15 项研究符合纳入标准。纳入的研究包括一项 RCT、一项病例系列研究、一项试点研究和 12 项队列研究:人群分析显示,所有研究中男性占多数,队列规模各不相同。80%的研究采用了戈利格痔疮基线分级。大多数研究(73.3%)采用经股动脉入路,60%的研究使用线圈作为主要栓塞材料,26.6%的研究使用线圈和微粒组合,6.6%的研究仅使用微粒。患者选择标准强调 RAE 适用于高手术风险患者、贫血患者、慢性血崩患者或治疗难治性病例。排除标准强调了既往手术、结直肠癌、直肠脱垂、急性痔疮并发症和造影剂过敏等因素。研究设计各不相同,以队列研究最为常见(12/15;80%)。手术细节包括使用金属线圈和可拆卸微线圈,大多数研究报告的技术成功率很高,从72%到100%不等。随访时间从 1 个月到 18 个月不等。大多数研究报告称,术中或术后无重大并发症:虽然所有研究都将 RAE 作为治疗 IH 的一种方法,但所纳入的研究之间存在很大程度的异质性,尤其是在纳入标准、排除标准、结果测量和时间范围方面。未来的文献应尝试将这些设计要素标准化,以帮助进行二次分析,并加深对 RAE 作为一种治疗方案的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CVIR Endovascular
CVIR Endovascular Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
2.30
自引率
0.00%
发文量
59
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信